�鶹��ý

Representative Experience*

• Representing the Chair of the Board of a large London-based life sciences company in connection with allegations against him lodged by the company CEO. The Chair was cleared of all allegations, and the CEO was asked to leave the company.
• Represented the board of Matterport, Inc. (NASD: MTTR) in connection with shareholder claims arising from the announcement of the company’s merger with CoStar Group, Inc.
• Representing the CEO and CRO of Silvergate Bank (NYSE: SI), primary bank for FTX and other major crypto currency exchanges in connection with numerous securities class actions and derivative actions filed by the bank’s shareholders and class actions by FTX’s investors.
• EMC Casualty Corporation – Led defense of multiple shareholder suits and appraisal claims against controlling shareholder of large publicly traded insurance company in connection with its US$350m “going-private” transaction. Obtained three unanimous favorable decisions from Iowa Supreme Court and Eighth Circuit Court of Appeals.
• Represented JPMorgan Chase Bank in connection with class action investor claims alleging that the bank aided and abetted a US$100m+ Ponzi scheme involving the sale of fictitious certificates of deposit, patterned after the Stanford C.D. Ponzi scheme. Successfully settled all claims for less than litigation costs.
• Represented the largest regional bank in Utah, Zions Bank, in connection with numerous class action and individual investor claims alleging that the bank aided and abetted the largest Ponzi scheme securities fraud in Utah history. Successfully settled all claims for less than litigation costs.
• Represented Kids2, Inc. in connection with its acquisition of publicly traded Summer Infant (NASDAQ: SMR). Settled for nominal damages multiple shareholder class action suits in connection with disclosures in proxy materials for the acquisition, and prevented the filing of a shareholder class action suit against Summer Infant after closure of the transaction.
• Representing Earlybird Capital, a leading innovator in the SPAC market, in connection with Delaware appraisal claims filed in the wake of its US$135m reorganization.
• Led the investigation by a Special Committee of the Board of Trustees of a major Boston-area university into conflict-of-interest and breach-of-fiduciary-duty allegations against the university president and the chair of the Investment Committee of the Board.
• Represented the president of Suffolk University in connection with an internal investigation by the Board of Trustees, amid widespread media coverage and attorney general investigation.
• In one of the leading “poison pill” cases in Delaware Chancery Court jurisprudence, represented Yucaipa American Alliance Fund and its principal Ron Burkle through trial in their challenge to the validity of the shareholder rights plan adopted by the board of directors of Barnes & Noble.
• Led the representation of a publicly traded government contractor in connection with an SEC investigation into the company’s restatement of its financial results, the withdrawal of its outside audit firm and the company’s public disclosures on other related issues. After a two-year investigation, the SEC decided not to pursue enforcement action against the company or impose any fines or penalties.
• Led the internal investigation involving the top executives of a publicly traded medical device company’s overseas operations engaged in internal accounting fraud, which resulted in the dismissal of the head of the overseas operations and other senior executives.

*Certain matters occurred prior to Beth joining �鶹��ý.